Over the last decade, there has been a dramatic rise in the number of PubMed and Google references about platelet-rich plasma. This represents worldwide interest in this point-of-care biologic treatment for a variety of research and clinical applications.
Patients are already seeing the benefits of this research and new breakthroughs will come from expected and unexpected sources.
Sunday, July 21, 2013
Thursday, July 04, 2013
The American Journal of Sports Medicine (AJSM) has just published the largest study evaluating platelet-rich plasma. The 230 patient study was conducted over the course of more than five years and represents the work of dozens of clinicians and researchers. Overall, it is clear from the data that the use of PRP to treat chronic tennis elbow results in significant reductions in pain and elbow tenderness compared to an active control of needling of the elbow without PRP. It is also safe and cost effective compared to cortisone and surgery. This type of study is time consuming and expensive but will help guide patient and physicians decisions about how to best treat chronic tennis elbow.
Here is a lay press article on the article from Healio.
Read the full AJSM Abstract below.
Platelet-Rich Plasma Significantly Improves Clinical Outcomes in Patients With Chronic Tennis Elbow
A Double-Blind, Prospective, Multicenter, Controlled Trial of 230 Patients